Updates in Viral Hepatitis in 2024—Summary of Education, Research and Leadership Activities of the ESCMID Study Group for Viral Hepatitis (ESGVH)
Author Contributions
Funding
Conflicts of interest
References
- Lok, A.S.F. Toward a functional cure for hepatitis b. Gut Liver. 2024, 18, 593–601. [Google Scholar] [CrossRef] [PubMed]
- Reiberger, T.; Lens, S.; Cabibbo, G.; et al. EASL position paper on clinical follow-up after HCV cure. J Hepatol. 2024, 81, 326–344. [Google Scholar] [CrossRef] [PubMed]
- Dietz-Fricke, C.; Degasperi, E.; Jachs, M.; et al. Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series. Hepatology. 2024, 80, 664–673. [Google Scholar] [CrossRef] [PubMed]
- Killer, A.; Gliga, S.; Lohr, C.; et al. Dynamics of virological and clinical response parameters of bulevirtide treatment for hepatitis d: real-world data. Gastro Hep Adv. 2024, 3, 353–360. [Google Scholar] [CrossRef] [PubMed]
- Chen, Y.J.; Lin, Y.C.; Wu, M.T.; Kuo, J.Y.; Wang, C.H. Prevention of viral hepatitis and HIV infection among people who inject drugs: a systematic review and meta-analysis. Viruses. 2024, 16, 142. [Google Scholar] [CrossRef] [PubMed]
- Conners, E.E.; Panagiotakopoulos, L.; Hofmeister, M.G.; et al. Screening and testing for hepatitis B virus infection: CDC recommendations — United States, 2023. MMWR Recomm Rep 2023, 72, 1–25. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030; WHO: Geneva, 2022. [Google Scholar]
- Dudman, S.; Zerja, A.; Hasanoğlu, İ.; et al. Global vaccination against hepatitis E virus: position paper from the European society of clinical microbiology and infectious diseases viral hepatitis study group. Clin Microbiol Infect. 2024, S1198-743X(24)00542-1. [Google Scholar] [CrossRef] [PubMed]
© GERMS 2024.
Share and Cite
Săndulescu, O.; Hasanoğlu, İ.; Matičič, M.; on behalf of ESGVH. Updates in Viral Hepatitis in 2024—Summary of Education, Research and Leadership Activities of the ESCMID Study Group for Viral Hepatitis (ESGVH). GERMS 2024, 14, 320-321. https://doi.org/10.18683/germs.2024.1442
Săndulescu O, Hasanoğlu İ, Matičič M, on behalf of ESGVH. Updates in Viral Hepatitis in 2024—Summary of Education, Research and Leadership Activities of the ESCMID Study Group for Viral Hepatitis (ESGVH). GERMS. 2024; 14(4):320-321. https://doi.org/10.18683/germs.2024.1442
Chicago/Turabian StyleSăndulescu, Oana, İmran Hasanoğlu, Mojca Matičič, and on behalf of ESGVH. 2024. "Updates in Viral Hepatitis in 2024—Summary of Education, Research and Leadership Activities of the ESCMID Study Group for Viral Hepatitis (ESGVH)" GERMS 14, no. 4: 320-321. https://doi.org/10.18683/germs.2024.1442
APA StyleSăndulescu, O., Hasanoğlu, İ., Matičič, M., & on behalf of ESGVH. (2024). Updates in Viral Hepatitis in 2024—Summary of Education, Research and Leadership Activities of the ESCMID Study Group for Viral Hepatitis (ESGVH). GERMS, 14(4), 320-321. https://doi.org/10.18683/germs.2024.1442